CRISPR Therapeutics AG announced a development partnership with ViaCyte Inc to develop genome-edited...
Up To Date
Latest News
Positive Phase 3 results with Sanofi/Regeneron's IL4/IL-13-targeting antibody dupilumab (Dupixent)...
Slowing the leak of Calcium leak into cardiomyocytes does not improve the pumping malfunction in heart...
EMBL Ventures has announced that its portfolio company ViraTherapeutics is set to be acquired by Boehringer...
Orphan drug leader Shire plc has been granted EU marketing authorization for its recombinant van Willebrand...
Drug Developers dealing with PD1-PDL1 checkpoint inhibitors must consider new safety problems associated with...
Share
